A.-R. Hanauske

Docetaxel and cisplatin: An active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck

Patrick Schöffski, G. Catimel, A.S.T. Planting et al. · Annals of Oncology · 1999 · 104 citations · Full text

Medicine, Pathology, Head And Neck Cancer +6

A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV

Simone Steinbild, K. Mross, Annette Frost et al. · British Journal of Cancer · 2007 · 101 citations · Full text

In vitro activity of aplidine, a new marine-derived anti-cancer compound, on freshly explanted clonogenic human tumour cells and haematopoietic precursor cells

H. Depenbrock, Robert Peter, G T Faircloth et al. · British Journal of Cancer · 1998 · 83 citations · Full text

Medicine, Haematopoietic Precursor Cells, Anti-cancer Agent +6

Phase I and pharmacokinetic study of Yondelis™ (Ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours

Chris Twelves, Klaas Hoekman, A. Bowman et al. · European Journal of Cancer · 2003 · 83 citations

Medicine, Pharmacology, Solid Tumours +6

Phase II trial of the oral platinum complex JM216 in non-small-cell lung cancer: An EORTC early clinical studies group investigation

Ian Judson, T. Cerny, Ron Epelbaum et al. · Annals of Oncology · 1997 · 54 citations · Full text

Phase Ii Trial, Non-small-cell Lung Cancer, Medicine +8